How have treatment patterns and survival rates for pulmonary arterial hypertension changed from 2010 to 2019?
Despite an increase in the use of combination therapy for pulmonary arterial hypertension between 2010 and 2019, 1-year survival rates have not significantly changed.
The use of combination therapy increased from 2010 to 2019, but most patients still received monotherapy. Survival rates at 1 year after diagnosis did not change over time. Future studies need to determine if the observed trend suggesting improved 3-year survival rates can be confirmed.
Hoeper et al. (Thu,) studied this question.